Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Air Canada T.AC

Alternate Symbol(s):  ACDVF

Air Canada is an airline company. The Company is a provider of scheduled passenger services in the Canadian market, the Canada-United States (U.S.) transborder market and the international market to and from Canada. It provides scheduled service directly to more than 180 airports in Canada, the United States and internationally on six continents. The Company’s Aeroplan program is Canada's premier travel loyalty program, where members can earn or redeem points on the airline partner network of 45 airlines, plus through a range of merchandise, hotel and car rental rewards. Its freight division, Air Canada Cargo, provides air freight lift and connectivity to hundreds of destinations across six continents using its passenger and freighter aircraft. Its Air Canada Vacations is a tour operator, which is engaged in developing, marketing, and distributing vacation travel packages in the outbound/inbound leisure travel market. Air Canada Rouge is Air Canada's leisure carrier.


TSX:AC - Post by User

Post by airlineinvestoron Nov 18, 2020 9:13am
874 Views
Post# 31921049

More Good News

More Good NewsThe most recent approval (see link below) by the FDA doesn’t seem to be getting a lot of media coverage today, perhaps overshadowed by Pfizer’s most recent announcement (completed study results on its vaccine’s efficacy now 95 percent.)
 
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-self-testing-home

 
Today’s announcement about a Covid-19 home test is not quite what I was referring to in my most recent post, but it is still one more game-changer in returning our lives to some sense of normalcy (See Pachuko’s post yesterday).
 

This home test will still require a prescription and from what I understand is on the pricey side.  However, expect similar less expensive products to come onto the market in the next month or two.  
 

I also see this approval as one step away from the consumer product type of home test (like pregnancy tests available at drug stores).  These tests are relatively inexpensive and do not require a prescription. 

 
Dr. Michael Mina, a Harvard professor and epidemiologist has been advocating for months the use of inexpensive home tests as a way of tackling the disease until a vaccine is developed and widely available.  The following two links provides background on his thinking:

 
https://news.harvard.edu/gazette/story/2020/08/cheap-daily-covid-tests-could-be-akin-to-vaccine/

 
Did Mina’s article in Time Magazine yesterday prompt this latest FDA approval? 

 
https://time.com/5912705/covid-19-stop-spread-christmas/?utm_source=twitter&utm_medium=social&utm_campaign=editorial&utm_term=ideas_covid-19&linkId=104733190
 
 
 
 
 
 
 
 
 
 
<< Previous
Bullboard Posts
Next >>